Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oh, T Y
Right arrow Articles by Hahm, K B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oh, T Y
Right arrow Articles by Hahm, K B
Topic Collections
Right arrowRelated Article
Gut 2001;49:364-371 ( September )

Article

Oxidative stress is more important than acid in the pathogenesis of reflux oesophagitis in rats T Y Ohb, J S Leec, B O Ahnb, H Chob, W B Kimb, Y B Kima, Y J Surhc, S W Choa, K M Leea, K B Hahma

a Department of Pathology and Gastroenterology, Ajou University School of Medicine, Suwon, Korea 442-749, b Dong-A Pharmaceutical Research Institute, Yongin, Kyunggi-do, Korea, c College of Pharmacy, Seoul National University, Seoul, Korea

Correspondence to: Dr K B Hahm, Department of Gastroenterology, Ajou University School of Medicine, Suwon, Korea 442-749. hahmkb{at}hotmail.com

Accepted for publication 29 March 2001

BACKGROUND---Although antisecretory medications such as histamine type II receptor antagonists or proton pump inhibitors have been used to treat reflux oesophagitis, a considerable number of patients do not achieve complete mucosal healing or suffer from either sustained symptoms or ensuing complications, suggesting other damaging factors or impaired mucosal resistance are also involved in the pathogenesis of reflux oesophagitis.
AIMS---The present study was designed to evaluate oxidative stress as the major pathogenic factor of reflux oesophagitis and to determine the usefulness of antioxidants in the treatment of reflux oesophagitis.
MATERIALS AND METHODS---Reflux oesophagitis was induced by insertion of a 3 mm calibre ring into the duodenum, 1 cm distal to the ligament of Treitz, in Sprague-Dawley rats.
RESULTS---DA-9601, a novel antioxidant substance, significantly attenuated the gross and histopathological scores of reflux oesophagitis compared with those treated with ranitidine alone or reflux oesophagitis controls in a dose dependent manner. Only scattered erosions were observed in the antioxidant pretreated group but acid suppression by ranitidine was not effective in decreasing the severity of reflux oesophagitis. Significantly increased amounts of malondialdehyde (MDA), increased nuclear factor kappa B (NFkappa B) activation, and depletion of reduced glutathione (GSH) were observed in experimentally induced reflux oesophagitis. DA-9601 pretreatment attenuated the decrement in mucosal GSH levels and decreased MDA formation significantly. DA-9601 treatment caused significant reductions in activation of NFkappa B transcription factor, especially the p50 subunit, in accordance with the significantly higher levels of inhibitory protein of NFkappa B expression.
CONCLUSION---Reflux oesophagitis caused considerable levels of oxidative stress in the oesophageal mucosa and antioxidant treatment should be considered as supplementary therapy in the prevention or treatment of reflux oesophagitis with acid suppression.


Keywords: reflux oesophagitis; antioxidants; oxidative stress; rat

© 2001 by Gut

Related Article

Beyond acid suppressants in gastro-oesophageal reflux disease
R C FITZGERALD
Gut 2001 49: 320-321. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
R. A. Risques, T. L. Vaughan, X. Li, R. D. Odze, P. L. Blount, K. Ayub, J. L. Gallaher, B. J. Reid, and P. S. Rabinovitch
Leukocyte Telomere Length Predicts Cancer Risk in Barrett's Esophagus
Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2649 - 2655.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. J. Murphy, A. E. Hughes, C. C. Patterson, L. A. Anderson, R.G.P. Watson, B. T. Johnston, H. Comber, J. McGuigan, J. V. Reynolds, and L. J. Murray
A population-based association study of SNPs of GSTP1, MnSOD, GPX2 and Barrett's esophagus and esophageal adenocarcinoma
Carcinogenesis, June 1, 2007; 28(6): 1323 - 1328.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. C. Finley, B. J. Reid, R. D. Odze, C. A. Sanchez, P. Galipeau, X. Li, S. G. Self, K. A. Gollahon, P. L. Blount, and P. S. Rabinovitch
Chromosomal Instability in Barrett's Esophagus Is Related to Telomere Shortening.
Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1451 - 1457.
[Abstract] [Full Text] [PDF]

Home page
 SURG INNOVHome page
Y. Erbil, U. Turkoglu, U. Barbaros, E. Balik, V. Olgac, H. Kaya, and B. Cimsit
Oxidative Damage in an Experimentally Induced Gastric and Gastroduodenal Reflux Model
Surgical Innovation, September 1, 2005; 12(3): 219 - 225.
[Abstract] [PDF]

Home page
 GutHome page
R C FITZGERALD
Beyond acid suppressants in gastro-oesophageal reflux disease
Gut, September 1, 2001; 49(3): 320 - 321.
[Full Text]

eLetters:

Read all eLetters

Two questions about DA-9601
David L Elliott
Gut Online, 7 Sep 2001 [Full text]

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2001 BMJ Publishing Group Ltd & British Society of Gastroenterology